Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

3 Months Ended

Nov. 30, 2022

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

13. Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities at November 30, 2022 and August 31, 2022 consist of the following:

		November 30,				August 31,
		2022				2022
		$				$
Accounts Payable
Trades payable			173,678				57,150
Sales tax payable			11,011				31,303
Accrued Liabilities
Trades payable			57,202				62,996
Balance			241,891				151,449